The Central Australian Heart Protection Study: A Randomised Trial of Nurse-Led, Family Based Secondary Prevention of Acute Coronary Syndromes.

Not Applicable

Recruiting

• Conditions: Acute Coronary Syndromes; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12614000284662
• Lead Sponsor: Baker IDI Heart and Diabetes Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

All patients admitted to the Alice Springs Hospital with the admission diagnosis of ST elevation myocardial infarction (STEMI), Non ST segment elevation ACS, or angina.

Aged over 18 years

Able to provide informed consent

Resident of Central Australia

Exclusion Criteria

Patients will be excluded if they do not survive to discharge, have a discharge diagnosis inconsistent with ACS, who are not residents of Central Australia (i.e. Interstate or international visitors), or who have a significant neurological/cognitive impairment that prevents informed consent being obtained

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Major Adverse Cardiovascular Endpoint (MACE) - death, non-fatal ACS, stroke, or unplanned revascularisation. Hospitalisation (hospital separation ICD-10) and vital statistics data (NDI propensity matched mortality data) will be collated on each individual at study close out, and according to standardised hospitalisation and event forms to be completed prospectively by individual case managers. Each event will have details collated and will be reviewed by a blinded outcome adjudication committee according to standardised outcome definitions. [2 years]